Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJPB.2005.02.015PMID 15893918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uptake of Melatonin into the Cerebrospinal Fluid After Nasal and Intravenous Delivery: Studies in Rats and Comparison with a Human Study

  2004cited by this paper
• Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.

  2004cited by this paper
• The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

  2004cited by this paper
• Direct access of drugs to the human brain after intranasal drug administration?

  2003cited by this paper
• Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans

  2003cited by this paper
• Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.

  2003cited by this paper
• Uptake of hydrocortisone into the cerebrospinal fluid of rats: comparison of intranasal and intravenous administration in the same animal

  2002cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.

  2002cited by this paper
• Enhancement of the Systemic and CNS Specific Delivery of L-Dopa by the Nasal Administration of Its Water Soluble Prodrugs

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice

  2000cited by this paper
• Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats.

  2000cited by this paper
• Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?

  1998cited by this paper
• Direct transport of 2',3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats.

  1998cited by this paper
• Investigation of the effect of anaesthesia on nasal absorption of insulin in rats

  1997cited by this paper
• Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailability.

  1997cited by this paper
• Distribution of antihistamines into the CSF following intranasal delivery.

  1997cited by this paper
• A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin

  1996cited by this paper
• Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs

  1995cited by this paper
• Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats.

  1994cited by this paper
• Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.

  1993cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Animal models for intranasal drug delivery studies. A review article.

  1990cited by this paper
• Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery.

  1990cited by this paper
• Subarachnoid space of the CNS, nasal mucosa, and lymphatic system.

  1979cited by this paper
• Passage of Fluid and Other Substances Through the Nasal Mucosa

  1958cited by this paper

• Changes in Cx43 and AQP4 Proteins, and the Capture of 3 kDa Dextran in Subpial Astrocytes of the Rat Medial Prefrontal Cortex after Both Sham Surgery and Sciatic Nerve Injury

  2024cites this paper
• Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain.

  2021cites this paper
• [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].

  2018cites this paper
• Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

  2016cites this paper
• Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration

  2015cites this paper
• Bypassing the blood–brian barrier using established skull base reconstruction techniques

  2015cites this paper
• Distribution of α-asarone in brain following three different routes of administration in rats.

  2014cites this paper
• Intranasal administration of oxytocin: Behavioral and clinical effects, a review

  2013cites this paper
• Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.

  2012cites this paper
• Translational pharmacology of intranasal administration of dopamine receptor agonists and antagonists

  2011cites this paper
• Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

  2010cites this paper
• Direct transport of VEGF from the nasal cavity to brain.

  2009cites this paper
• Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.

  2007cites this paper
• Pharmacokinetics of Gastrodin in rat plasma and CSF after i.n. and i.v.

  2007cites this paper
• Can Nasal Drug Delivery Bypass the Blood-Brain Barrier?

  2007cites this paper
• Nasal drug delivery : A direct approach to the cerebrospinal fluid?

  2005cites this paper